Cite
Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors.
MLA
Sacks, Frank M., et al. “Coronary Heart Disease in Patients with Low LDL-Cholesterol: Benefit of Pravastatin in Diabetics and Enhanced Role for HDL-Cholesterol and Triglycerides as Risk Factors.” Circulation, vol. 105, no. 12, Mar. 2002, pp. 1424–28. EBSCOhost, https://doi.org/10.1161/01.cir.0000012918.84068.43.
APA
Sacks, F. M., Tonkin, A. M., Craven, T., Pfeffer, M. A., Shepherd, J., Keech, A., Furberg, C. D., & Braunwald, E. (2002). Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors. Circulation, 105(12), 1424–1428. https://doi.org/10.1161/01.cir.0000012918.84068.43
Chicago
Sacks, Frank M, Andrew M Tonkin, Timothy Craven, Marc A Pfeffer, James Shepherd, Anthony Keech, Curt D Furberg, and Eugene Braunwald. 2002. “Coronary Heart Disease in Patients with Low LDL-Cholesterol: Benefit of Pravastatin in Diabetics and Enhanced Role for HDL-Cholesterol and Triglycerides as Risk Factors.” Circulation 105 (12): 1424–28. doi:10.1161/01.cir.0000012918.84068.43.